Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for prevention of manic episodes in bipolar disorder
2005-005072-32Phase 4Completed
- Sponsor
- King's College London
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of quetiapine in bipolar disorder (BD), sponsored by King's College London. Primary endpoint: Change in YMRS score over time. Started Oct 2005; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2005-005072-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005072-32.